Default company panoramic image
Logo

Gema Diagnostics

Gema is developing noninvasive human oocyte and embryo selection methods to fundamentally improve the prospects for in vitro fertilization.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Ann Arbor, MI, USA
  • Currency USD
  • Founded September 2005
  • Employees 2
  • Website gemadx.com

Company Summary

For many people who want to start a family, the dream of having a child is not easily realized. Of those who can afford in vitro fertilization (IVF), only 30% succeed in giving birth. Gema's diagnostic tests will give IVF practitioners the tools they lack to be able to objectively and non-invasively select the healthiest, most-viable embryos, thereby dramatically improving the odds of clinical success.

Team

  • Default avatar
    Dave Repp
    Chief Operating Officer

    Mr. Repp has 15 years of experience in research commercialization, new venture creation, and business consulting in the life sciences and technology. He co-founded and was VP of Bus. Ops. for Avidimer Therapeutics a venture backed biotech developing targeted drug technologies. Mr. Repp holds an MBA (Samuel Zell Scholar) from the Ross School of Business at the University of Michigan and MS in Mechanical Engineering from the University of Michigan.

  • Default avatar
    Jose Cibelli
    Founder and Chief Scientific Officer

    Dr. Cibelli is a pioneer in cloning with transgenic somatic cells and embryonic stem cells – he and his team generated the world's first transgenic cloned calves, the first embryonic stem cell line from humans by nuclear transfer, and the first embryonic stem cells by parthenogenesis in primates. Dr. Cibelli earned his PhD in Reproductive Physiology at the University of Massachusetts and his DVM from the University of La Plata.

  • Default avatar
    Amy Iager
    Director of Research & Development

    Ms. Iager has ten years of experience in embryology, molecular biology, and cell culture research. Ms. Iager earned her MS in Animal Biotechnology from Michigan State University with a focus on research in embryology and gene expression analyses in embryos.

Previous Investors

  • Default avatar
    North Coast Technology Investors
    Unconfirmed
    Default avatar
    The Dow Chemical Company
    Unconfirmed
    Default avatar
    Blue Water Angels
    Unconfirmed